Płachcińska Anna, Mikołajczak Renata, Kozak Józef, Rzeszutek Katarzyna, Kuśmierek Jacek
Department of Nuclear Medicine, Medical University, Łódź, Poland.
Nucl Med Rev Cent East Eur. 2004;7(2):143-50.
The aim of the study was the assessment of the clinical usefulness of scintigraphy with (99m)Tc-EDDA/HYNIC-TOC for purposes of a differential diagnosis of SPNs by means of a visual inspection and semi-quantitative assessment of uptake intensity of the radiopharmaceutical (RPh).
In 53 patients (32 males and 21 females at the ages between 38 and 78 years, mean value 57) with SPN on chest radiographs or CT scans, of diameters from 1 to 5.5 (mean 2.3) cm a SPECT acquisition was performed, 2-4 h after administration of 740 MBq of RPh. Additionally, aiming at the implementation of a correction of a partial volume effect resulting from finite resolution of this technique, the measurement of the resolution of this technique was performed on an thorax phantom. Scintigraphic studies were inspected visually visually and semi-quantitatively, restoring real concentration of the RPh in nodules in comparison with the peritumoral background (tumour-to-background ratio) by the application of resolution recovery coefficients for the respective nodule diameters. The threshold values of tumour-to-background ratio providing optimal differentiation between malignant and benign nodules of sizes smaller and larger than 2 cm in diameter were determined. Verification of scintigraphic results was based on pathological examinations of tumour samples (histopathology or cytology) and in some cases on bacteriological studies. The additional criterion of tumour benignity was accepted, based on its stable size in a time interval no shorter than 3 years.
In 32 patients the following malignant tumours were diagnosed: 12 adenocarcinomas, 6 squamous cell carcinomas, 6 non-small cell lung cancers of unspecified more detailed morphology, 2 large cell carcinomas, 2 small cell lung cancers, 2 carcinoids and 2 metastatic lesions (malignant melanoma and leiomyosarcoma). In 21 patients benign etiologies were found: 6 tuberculomas, 2 other granuloma, 4 hamartomas, 2 non-specific inflammatory infiltrate, 1 alien body with inflammatory reaction and 1 suppurating inflammatory lesion, 1 abscesses, 1 peripheral carcinoid of morphological features of a benign tumour, 2 tumours of unspecified etiology with sizes stable over 3 and 5 years, and 1 ectopic lesion of thyroid tissue. A visual inspection of scintigrams revealed enhanced uptake of RPh at 29 of 32 sites corresponding to locations of malignant nodules, in 2 cases (1 adenocarcinoma and 1 metastatic lesion of malignant melanoma) results were negative and in 1 (metastatic leiomyosarcoma) equivocal; in 13 of 21 benign nodules true negative results were obtained, in 4--positive (foreign body with inflammatory reaction, abscess, suppurating inflammatory lesion and tuberculoma), in the next 4--equivocal (2 tuberculomas, 1 hamartoma, 1 tumour of unspecified aetiology, but with a stable size over 3 years). The mean values of tumour-to-back-ground ratio without resolution recovery in malignant and benign nodules equalled 4.6 (sd 5.9) and 1.8 (sd 1.2), resp. (p = 7 x 10(-4)), while after resolution recovery coefficients--7.8 (sd 7.2) and 2.7 (sd 2.8), resp. (p = 2 x 10(-4)). The semi-quantitative method resulted in true positive results in 29/32 malignant cases and true negative in 15/21 benign cases.
(99m)Tc-EDDA/HYNIC-TOC scintigraphy is a very promising method for the differentiation of SPNs. The semi-quantitative method using resolution recovered tumour-to-background ratio enables the differentiation of malignant and benign SPNs based on the intensity of RPh uptake and facilitates the making of a decision as to the positive or negative scintigraphic character of the equivocal lesions.
本研究的目的是通过对放射性药物(RPh)摄取强度进行视觉检查和半定量评估,来评估(99m)Tc-EDDA/HYNIC-TOC闪烁扫描术在肺内孤立性结节(SPN)鉴别诊断中的临床实用性。
对53例患者(32例男性,21例女性,年龄38至78岁,平均57岁)进行研究,这些患者的胸部X线片或CT扫描显示有SPN,直径为1至5.5(平均2.3)cm。在给予740 MBq的RPh后2至4小时进行SPECT采集。此外,为了校正由于该技术有限分辨率导致的部分容积效应,在胸部体模上进行了该技术分辨率的测量。对闪烁扫描研究进行视觉和半定量检查,通过应用各个结节直径的分辨率恢复系数,恢复结节中RPh的真实浓度,并与瘤周背景进行比较(肿瘤与背景比值)。确定了在直径小于和大于2 cm的恶性和良性结节之间提供最佳鉴别的肿瘤与背景比值阈值。闪烁扫描结果的验证基于肿瘤样本的病理检查(组织病理学或细胞学),在某些情况下基于细菌学研究。基于肿瘤在不短于3年的时间间隔内大小稳定,接受了肿瘤良性的附加标准。
32例患者被诊断为以下恶性肿瘤:12例腺癌、6例鳞状细胞癌、6例形态学未进一步明确的非小细胞肺癌、2例大细胞癌、2例小细胞肺癌、2例类癌和2例转移瘤(恶性黑色素瘤和平滑肌肉瘤)。21例患者发现良性病因:6例结核瘤、2例其他肉芽肿、4例错构瘤、2例非特异性炎性浸润、1例伴有炎性反应的异物、1例化脓性炎性病变、1例脓肿、1例具有良性肿瘤形态特征的外周类癌、2例病因不明但在3年和5年内大小稳定的肿瘤以及1例甲状腺组织异位病变。对闪烁扫描图的视觉检查显示,在32个对应恶性结节位置的部位中有29个RPh摄取增强,2例(1例腺癌和1例恶性黑色素瘤转移瘤)结果为阴性,1例(平滑肌肉瘤转移瘤)结果不明确;21个良性结节中有13个获得真阴性结果,4个为阳性(伴有炎性反应的异物、脓肿、化脓性炎性病变和结核瘤),另外4个不明确(2例结核瘤、1例错构瘤、1例病因不明但大小稳定超过3年的肿瘤)。恶性和良性结节未进行分辨率恢复时肿瘤与背景比值的平均值分别为4.6(标准差5.9)和1.8(标准差1.2)(p = 7×10⁻⁴),而应用分辨率恢复系数后分别为7.8(标准差7.2)和2.7(标准差2.8)(p = 2×10⁻⁴)。半定量方法在32例恶性病例中有29例得到真阳性结果,在21例良性病例中有15例得到真阴性结果。
(99m)Tc-EDDA/HYNIC-TOC闪烁扫描术是鉴别SPN的一种非常有前景的方法。使用分辨率恢复后的肿瘤与背景比值的半定量方法能够根据RPh摄取强度区分恶性和良性SPN,并有助于对不明确病变的闪烁扫描特征做出阳性或阴性的判断。